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Abstract
Toxoplasma gondii infects approximately one third of the population worldwide. There is strong
evidence that a relationship between T. gondii titer and depressive symptoms exists. There is also
evidence suggesting a protective effect of RhD positive blood factor on toxoplasma-induced
behavioral and personality changes. This protective effect may influence the relationship
between T. gondii and prenatal depressive symptoms. The purpose of this secondary data
analysis was to examine the possible protective effect of RhD positive blood factor on prenatal
depressive symptoms in 56 pregnant women with T. gondii infection. The cross-sectional design
was utilized to answer the question “Does positive RhD blood factor provide a protective effect
on prenatal depressive symptoms of patients infected with T. gondii when controlling for
ethnicity, race, income, marital status, age and stress?” The conceptual model hypothesized that
there was a relationship between socio-demographic variables (age, income, marital status, race,
and ethnicity), stress, positive T. gondii titers, RhD positive blood factor, and prenatal depressive
symptoms. Pearson correlations and multiple regression were utilized to explore the aims of this
study demonstrated in the four statistical models. Significant relationship between stress and
positive T.gondii seropositivity on prenatal depressive symptoms was identified. There was no
significant relationship identified between RhD positive blood factor on the pregnant women
infected with T. gondii which could be attributed to the small sample size.
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Chapter One
Introduction and Background
Toxoplasma gondii, an intracellular protozoan parasite transmitted through cat feces,
infects approximately 30% of the population worldwide, with a higher prevalence in women than
men; (23.7% versus 10.9%) (Flegr & Striz, 2011). Since the early 1920’s Toxoplasma gondii (T.
gondii) infection was known to be transmissible to the unborn fetus, resulting in severe brain
damage and/or death (McAuliffe, 2012). The biology of the life cycle of T. gondii begins with
only felids shedding the infected, environmentally resistant, oocytes of the parasite in the fecal
material. The infection is then transmitted when the human inadvertently ingests the infective
oocytes, such as while cleaning litter boxes, gardening where cats defecate, playing in sand
boxes and/or ingesting uncooked meat or contaminated food or water. Once ingested, the oocyte
converts to the tachyzoite form and spreads through the body which can cause sudden acute
disease. After the primary infection, the parasites become confined to intracellular cysts in the
form of bradyzoites, becoming dormant for months to years (Dyer & Stoltenow, 2001).
Acute toxoplasmosis, although responsible for devastating effects for the infant including
hydrocephaly, intra-cerebral calcifications, microcephaly, and miscarriage in the immune
compromised, is easily misdiagnosed as common bacterial or viral infections (Flegr & Striz,
2011). Toxoplasma gondii may become dormant for years after the acute phase within the human
host resulting in specific behavioral and physiological effects (Flegr & Striz). The early studies
of T. gondii infection reported that behavioral changes occurred in the intermediate host (Flegr,
Zitkova, Kodym, & Frynta, 1996). Latent T. gondii infection is characterized by life-long cysts
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within the brain and muscle. (Flegr & Havlicek, 1994). There is evidence supporting possible
influences of latent T. gondii on rat and human behaviors and personality attributes (Flegr,
Zitkova, Kodym, & Frynta, 1996). Latent Toxoplasma-induced personality changes are reported
as behavioral changes, personality changes, gender specific changes, and possible links to
psychiatric disorders (Lindova, Priplatova, & Flegr, 2011). There appears to be a positive
correlation between length of latent toxoplasmosis infection and decreased intensity of superego
strength, suggesting a toxoplasma-induced willingness to accept group moral standards
(Lindova, Priplatova, & Flegr).
Flegr and Hrda (1994) found no significant influence of acute toxoplasmosis on human
personality or behavior. Chronic modification of the immune system in response to the parasite
in the brain may be responsible for effects noted in chronic, latent infection. Flegr and Havlicek
(1999) conducted research on a group of 191 women in the Czech Republic, where T. gondii
prevalence is above 50%. The toxoplasma-infected women were found to have “higher
intelligence, lower guilt proneness, and possibly higher ergic tension” (p.22). Flegr, Kodym, and
Tolarova (2000) followed-up with research that recognized increased toxoplasma-induced
personality differences correlated with longer durations of infection.
Flegr (2010) discussed the evidence for a strong association between toxoplasmosis and
schizophrenia. Flegr suggested that the long term effects of the T. gondii infection might trigger
the psychiatric disorder. There is also evidence of an increased risk of suicide and risk of traffic
accidents in latently infected individuals (Flegr, Novotna, Lindova & Havlicek, 2008; Novatna et
al., 2008; Yereli et al., 2006). Flegr (2010) suggested a potentially protective effect of the Rh
positive blood group in response to the deteriorating psychomotor and psychiatric toxoplasmainduced effects. Holub et al., (2011) provided evidence of the possible protective effect of Rh
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factor in the toxoplasma positive schizophrenia patients. The Rh positive patients exhibited
decreased schizophrenic symptoms. Ling, Lester, Mortensen, Langenberg, and Postalache,
(2011) provided evidence of the association between patients seropositive T. gondii and
increased risk for suicide. Girardi et al. (2012) provided evidence of the relationship of
depression and increased suicide rates in women soon after delivery. There is well-known
relationship between prenatal and postpartum depression (Whisman, Davila, & Goodman, 2011).
Arling et al., (2009) also provides evidence of higher T. gondii titers in suicide attempters
compared to controls. Groer et al., (2011) found an association between depressive symptoms
and T. gondii titer in infected pregnant women.
Human blood is categorized within two main systems: the ABO system and the Rhesus
(Rh) system. The RhD protein is the RhD gene product and a major component of the Rh blood
group system and carries the D-antigen, the strongest blood group immunogen (Pilgrim, LloydJones, & Rees, 2009). When RhD negative mothers deliver a child that is RhD positive, the fetal
cells left in the maternal circulation post delivery may cause the mother to develop anti-D
antibodies and become RhD sensitized. Although the sensitization is not likely to affect the
present fetus, the sensitization may result in future Rh positive pregnancies ending in hemolytic
disease in the newborn. Providing prophylactic anti-D to RhD-negative mothers to prevent
hemolytic disease of the fetus and newborn has been considered one of the most successful
clinical applications of antibody-mediated immunosuppression (Kumpel, 2008,). The rates of
RhD negative Caucasian, African, and Asian women are about 15%, 8%, and 1% respectively.
(Flegr et al., 2009).
Flegr, Novotna, Lindova and Havlicek (2008) suggest “the RhD protein acts as an ion
pump of uncertain specificity and unkown physiological role” (p.476). Novotna et al. (2008)
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provide evidence of a protective effect of the RhD protein on toxoplasma-induced psychomotor
performance impairment. The protective effect resulted in increased reaction times of the RhD
positive participants. Kankova, Sulc and Flegr (2010) offer evidence supporting the protective
effect of RhD positive blood factor against increased weight gain in pregnant women with latent
toxoplasmosis. No research to date has examined the protective effect of RhD positive blood
factor, T. gondii and prenatal depressive symptoms. The identification of the potential unique
relationship between the protective effect of RhD positive blood factor, latent toxoplasmosisinduced effects and prenatal depression may have significant worldwide implications.
The World Health Organization predicts that depression will be the second leading cause
of premature death and morbidity by 2020 and suicide is one of the most common causes of
maternal death in the year following delivery in developed countries (World Health
Organization, 2012). Wylie, Hollins Martin, Marland, Martin, and Rankin (2011) characterized
depression as psychological behavioral changes such as a depressed mood, hopelessness,
anxiety, excessive fatigue, psychomotor agitation, appetite and sleep disturbances, guilt and/or
feelings of inadequacy. Prenatal depression occurs in up to 20% of pregnant women, but is not
well understood and has also been associated with negative pregnancy and fetal outcomes and is
suggested to be a predictor of postpartum depression (Stillwaggon, Carrier, Sautter, & McLeod,
2011).
Statement of Problem
Toxoplasma gondii, an intracellular protozoan parasite, infects over 30% of the
population worldwide. Latent toxoplasma-induced behavioral and personality effects on the
intermediate host are significant with evidence that latent T. gondii causes personality and
behavioral changes, postpartum depression and anxiety. There is strong evidence that a
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relationship between T. gondii titer and depressive symptoms exists. There is also evidence
suggesting a protective effect of RhD positive blood factor on toxoplasma-induced behavioral
and personality changes. This protective effect may influence the relationship between T. gondii
and prenatal depressive symptoms. Research suggests that prenatal depression is a predictor of
postpartum depression. If this unique relationship between the protective effect of RhD positive
blood factor and toxoplasma-induced depression in pregnant women is present, this may increase
the effectiveness of predicting postpartum depression, thus, reducing the second leading cause
of suicide in post partem women with depression.
Statement of Purpose
The purpose of this exploratory investigation was to examine the protective effect of RhD
positive blood factor on the relationship between T. gondii and prenatal depressive symptoms.
The covariates, ethnicity, race, income, marital status, age, stress, and RhD positive blood factor
were evaluated for their relationship to prenatal depressive symptoms of patients infected with T.
gondi. Controlling for these covariates, the unique relationship of Rh positive blood factor on
prenatal depressive symptoms of T. gondii infected patients was examined. The exploration of
this potentially unique relationship may provide support for future research into the possible
protective effect of Rh positive on post partum depression, the second leading cause of maternal
death today.
Specific Aims
The proposed research question was “Does positive RhD blood factor provide a
protective effect on prenatal depressive symptoms of patients infected with T. gondii when
controlling for ethnicity, race, income, marital status, age, and stress?” The specific aims for this
research are as follows:
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1.) Examine the relationship of ethnicity, race, income, marital status, age, and stress on
prenatal depressive symptoms in 56 positive T. gondii infected pregnant women who are
between 16-25 weeks gestation.
2.) Examine the relationship of positive T. gondii status and prenatal depressive
symptoms.
3.) Examine the relationship of Rh status and prenatal depressive symptoms.
4.) Examine the moderating effect of Rh status on the relationship between T.gondii and
prenatal depressive symptoms.
Definitions of Relevant Terms
Ethnicity is defined as Hispanic or Latino and non-Hispanic or Latino. Race is defined as
American Indian/Alaska Native, Asian, Native Hawaiian or other Pacific Islander, Black or
African American, and White.
Wylie, Hollins Martin, Marland, Martin, and Rankin (2011) characterized depression as
psychological behavioral changes manifesting in symptoms such as a depressed mood,
hopelessness, anxiety, excessive fatigue, psychomotor agitation, appetite and sleep disturbances,
guilt and/or feelings of inadequacy.
Assumptions
The assumption was made that the assays utilized to identify T. gondii positive infection
are validated through manufacturer standards. The assumption was made that the instruments
utilized would measure the covariates as defined. The self-report nature of the demographic and
psychosocial data may affect reliability and validity of the scores.
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Relevance and Significance
Pregnant women are currently provided with information warning against the risks of
toxoplasmosis and ways to avoid the infection, but no formal screening is recommended.
Although congenital toxoplasmosis is a preventable disease in pregnancy, estimated 500-5000
infants are born each year in the United States resulting in a significant emotional and economic
burden from the sequelae of the disease for the parents and society (Montoya & Remington,
2008). Stillwaggon, Carrier, Sautter, and Mcleod (2011) estimate maternal serologic screening
for T. gondii during pregnancy would provide a savings of $620/child screened, also reducing the
number of congenital cases to 1/10,000.
Although there are many studies examining prenatal and postpartum depression, there is
only one study was found examining the relationship of T. gondii and prenatal depressive
symptoms. Additionally, no studies have been found on the relationship of the protective effect
of RhD positive blood factor in pregnant patients with T. gondii and prenatal depressive
symptoms. The ability to identify a protective effect of RhD positive blood factor on prenatal
depressive symptoms of patients infected with T. gondii may allow for improved screening
techniques and may provide improved surveillance for postpartum depression and suicide postdelivery to avoid or reduce the profound negative maternal and fetal outcomes. Including
toxoplasma surveillance and subsequent identification of Rh negative women at risk for
psychological behavior changes and postpartum depression may lead to a reduction of maternal
suicide, the second most prevalent cause of maternal death in the United States.

8

Chapter Two
Review of the Literature
The research domains of T. gondii, Rhesus D blood factor, prenatal depression and
postpartum depression were utilized to conduct a comprehensive literature review using
Academic Search Premier, Cochrane Database of Systemic Reviews and the Cumulative Index
to Nursing and Allied Health Literature (CINAHL), Cochrane Central Register of Controlled
Trials, MEDLINE, PsycINFO, and PubMed databases first in isolation and then jointly using the
Boolean operator and. The literature review was divided into areas of relevance for convenience
of the review. The review was categorized by primary headings of Toxoplasma gondii,
personality and behavioral changes, Rhesus D blood factor, preterm and postpartum depression.
Within each area the content of research was presented chronologically.
State of the Science: Toxoplasma gondii
Since the early 1920’s T. gondii infection was known to be transmissible to the unborn
fetus, resulting in severe brain damage and/or death (McAuliffe, 2012). For the past forty years
pregnant women have been warned regarding the dangers of exposure to cat feces and
subsequent risk of exposure to T. gondii. The Centers for Disease Control and Prevention (CDC)
noted that over a third of the world’s human population was estimated to carry T. gondii
infection with an 11% seroprevalence in women of childbearing age (CDC, 2009). The more
recent statistics reveal that the T. gondii oocytes excreted by cats in their feces, infect
approximately 30% of the population worldwide, with a prevalence rate significantly higher in
females than in males (23.7% and 10.9%, respectively) (Flegr & Striz, 2011). Transmission of T.
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gondii to humans occurs in various ways such as, consumption of raw or undercooked meat
containing the tachyzoites in cat feces, or eating poorly washed fruits and vegetables
contaminated with oocytes (Adesiyun et. al., 2011). The detection of T. gondii immunoglobulin
(IgG) is used as evidence of past exposure/infection and detection of immunoglobulins M (IgM)
for the evidence of acute/current infection (Adesiyun).
Although one third of the population of the United States is infected with the T. gondii
parasite, the T. gondii infection rate, in other areas of the world, is estimated to be 10 to 90%
(Stokkerman, Schwartzman, Keenan, Morrissette, Tilney, & Roos, 1996). Stokkerman et al.
described the T. gondii parasite as an ‘opportunistic pathogen’ of the immunocompromised due
to the reactivation of the cysts which lay dormant for the host’s life. The rodent research
conducted by Salibay and Claviera (2005) provided evidence identifying rodents as chronic
carriers of the toxoplasma infection, which remains within the host rodents even though not
immune compromised.
The prospective cross-sectional survey conducted by Kolbekova, Kourbatova, Novotna,
Kodym and Flegr (2007) on 3290 military personnel in Prague, Czechoslovakia, identified risk
factors for transmission of the T. gondii infection. The risk of infection increased significantly
with age (25-34) when compared to ages younger than 25 years, childhood residence in towns
with less than 10,000 residents being married, and being a professional member of the military.
Toxoplasma infection risk was also significantly higher in subjects that ate raw meat, were cat,
dog or rabbit owners, and had the blood groups A, B, or AB. The authors reported an overall
seroprevalence of 23% with 26.3% in male population and 29 – 37% in pregnant women
(Kolbekova, Kourbatova, Novotna, Kodym, & Flegr).
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Acute T. gondii acquired during pregnancy with transmission to the fetus usually has
devastating yet preventable effects on the fetus resulting in but not limited to visual and hearing
loss, mental and psychomotor disabilities, seizures, blood disorders and possible death (Montoya
& Remington, 2008). Most of the pregnant women who acquire the disease during pregnancy are
asymptomatic. In the United States, serological screening on all pregnant women, although
optimal for detecting the disease, is not mandatory. Unlike the United States, countries such as
France and Austria require serological testing in pregnancy for early detection of the disease.
Serological testing is done to detect and quantify the T. gondii antibodies in the serum of
pregnant women and to establish if the disease exposure is recent or in the distant past. The
negative IgG and IgM would suggest no infection has occurred, while a positive IgG and
negative IgM indicates the infection has occurred in the distant past. The diagnosis of the disease
is facilitated not only by the serology but also by history and examination of the pregnant patient.
The addition of the fetal ultrasound also provides valuable information related to the presence of
fetal abnormalities including brain, spleen, and hepatic abnormalities, and ascites. Although the
disease is treatable with antibiotic therapies, primary prevention utilizing educational material
continues to be the predominant focus for prevention of T. gondii in pregnant women. In addition
to this primary educational prevention, women who are found to be sero-positive for T. gondii
must be advised of their options related to termination of their pregnancy, and antibiotic therapy
in utero (Montoya & Remington, 2008).
Flegr, Hrda, and Kodym (2005) conducted an analysis of the clinical records of 758
women tested in their 16th week of pregnancy for toxoplasmosis. One hundred seventy-four
women were found to be positive for T. gondii and significantly below normal body weight for
their 16th week of gestation. Although when length of gestation and maternal age were also
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examined there were no significant differences in patients who had positive and negative T.
gondii titers. The lower body weight reported in this research supports the negative influence of
T. gondii on pregnant women (Flegr, Hrda, & Kodym).
Kankova, Holan, Zajicova, Kodym, and Flegr (2010) suggested the modulation of the
immunity in mice infected with latent toxoplasmosis. The mice demonstrated a decreased
production of interleukin-2 and nitric oxide and synthesis of DNA. Knowing that approximately
30% of the world’s population is infected with latent toxoplasmosis, it was suggested that the T.
gondii associated immunosuppression might result in a serious public health concern (Kankova
et. al.). Flegr and Striz’s (2011) research on rodents provides evidence of the potential
immunosuppressive effects of latent toxoplasmosis also suggesting subsequent serious public
health concerns.
Personality and Behavioral Changes
Flegr, Zitkova, Kodym, and Frynta (1996) found a high incidence of latent T. gondii in
London, New York, and Paris with an estimated 22%, 32%, and 84% of pregnant women,
respectively, as an opportunity to investigate the influences of T. gondii on human behavior. The
research data were collected over 26 months in 1992-1994. The Cattell’s 16-factor questionnaire,
(form A), measures personality characteristics. Two experimental sets consisted of the first set of
224 men and 170 women students from Charles University, Prague, and the second set of 190
men from various Prague hospitals, all infected with acute toxoplasmosis within the past 13
years. The relationships of toxoplasmosis, gender, and the toxoplasma-gender interactions on
personality factors were evaluated utilizing a multivariate analysis of covariance (MANCOVA).
Although the toxoplasmosis and gender factors on personality factors were not significantly
different, the interaction of toxoplasmosis-gender on personality factors was highly significant.
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Five personality factors were isolated as significantly influencing the difference in the
toxoplasmosis-gender interaction. Flegr, Zitkova, Kodym, and Frynta’s (1996) research
suggested the existence of a correlation between human personality and the duration of the
toxoplasmosis. The data revealed that there was more likelihood that the correlation suggested
the duration of toxoplasmosis induced personality changes versus the personality changes being
the cause of the probability of becoming infected with T. gondii.
Havlicek, Gasova, Smith, Zvara, and Flegr’s (2000) research supports the supposition
that after the initial acute infection, the infection moves into a dormant/latent phase in which the
cysts form and survive in the tissues for the duration of the human hosts lifespan. The double
blind study was conducted in the Institute of Haematology and Blood Transfusion, in Prague.
The sample for the experimental set included 69 men and 47 women, and donors of
thrombocytes, who participated in reaction time testing over three time frames of one, two and
three minute intervals. Computerized psychomotor testing and enzyme-linked immunosorbent
assay (ELISA) testing for IgG and IgM antibody titers for T. gondii were performed.
Complement fixation tests (CFT) were conducted to differentiate between acute and latent
toxoplasmosis. CFT titers between 1:8 and 1:128 were considered positive for latent
toxoplasmosis. Analysis of covariance (ANCOVA), controlling for age, revealed a significantly
longer reaction time for toxoplasmosis positive subjects versus the toxoplasmosis negative
subjects. The correlation between duration of toxoplasmosis and slower reaction times became
significantly longer with each time frame interval. These results demonstrated the deteriorative
effects of latent toxoplasmosis on subject’s concentration over the three time intervals (Havlicek,
Gasova, Smith, Zvara, & Flegr).
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Flegr et al (1996) rodent research data have suggested that although asymptomatic, rats
with latent toxoplasmosis became immune-compromised, leading up to and including death.
Although latent toxoplasmosis is known to be asymptomatic, studies have been conducted
suggesting the manipulative effect of the dormant parasite on the human personality (Flegr et al.,
1996; Flegr, Kodym & Tolavora, 2000; Flegr, Priess, Klose, Havlicek, Vitakova, & Kodym,
2003; Flegr & Havlicek, 1999). Flegr, Hrda, and Kodym (2005) tested 758 women in their 16th
week of gestation for T. gondii. The women positive for T. gondii were found to have a
significantly lower body weight at 16 weeks than women who were negative for T. gondii (p =
0.02). Although there were unusual findings suggesting longer length of gestation for patients
positive for T. gondii, the negative impact on general health of this population may be a more
significant factor (Flegr, Hrdy & Kodym).
Simpore, et al. (2006) provided evidence of increasing seroprevalence of T. gondii in subSaharan Africa with an increase in the human immunodeficiency virus (HIV), hepatitis B virus
(HBV), and hepatitis C virus (HCV). This may support the negative impact of latent T. gondii on
general health of the immunocompromised. It is more likely that the immune compromise of
these diseases leads to increased susceptibility for primary infection and increased reactivation of
latent infections. Of the 336 pregnant women in an antenatal clinical at Saint Camille Medical
Centre in Ouagadougou, Burkina Faso, 207 were HIV positive, 129 were HIV negative, and
25.3% (85/336) were found to have positive T. gondii IgG antibodies (Simpore et al).
Skallova et al. (2005) reported the prevalence of T. gondii infection was 34.1% in 205
men and 27.1% of the women. The research suggests that the participants with latent
toxoplasmosis were at higher risk for schizophrenia. The missing link between toxoplasmosis
and schizophrenia was speculated to be inflammation-induced increases in dopamine. Also the
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decreased novelty seeking behaviors of the toxoplasma infected blood donors was also linked to
this increase in dopamine (Skallova et al.). Skallova, Kodym, Frynta, and Flegr (2006) provided
evidence of a probable change in the dopaminergic system induced by T. gondii infection. Of the
mice utilized in this research, the T. gondii positive females were found to be more explorative of
the environment in which they were placed and there was a slight weight loss coinciding with the
immune system compromise. Although they were unable to provide a definitive link between
possible T. gondii-induced behavioral changes, future research combining neurochemical and
ethological studies may facilitate a better understanding of the physiological mechanism of T.
gondii-induced behavioral changes (Skallova, Kodym, Frynta, & Flegr).
Manipulation theory is characterized by the ability of the parasite to modify the behavior
of the host through an evolutionary process to increase the efficiency of the parasitic
transmission to the uninfected host (Kankova et al., 2007; Flegr, 2007; Voozen, 2007). The
manipulation of behavior found in T. gondii positive animals impairs motor performance
(Hutchinson, Aitken, & Wells, 1980), produces learning deficits (Witting, 1979), increases
trapability (Webster, 1994), and causes loss of cat urine odor avoidance (Berdoy, Webster, &
MacDonald, 2000). Based on the manipulation theory, Kankova, Kodym, Frynta, Varinova,
Kubena, and Flegr (2007) investigated the influence of latent toxoplasmosis on the secondary sex
ratio in mice suggesting that a deviated sex ratio was a product of the manipulative activity of the
parasitic organism, T. gondii. In conjunction with the manipulation theory, evidence has reported
that pregnant women with latent T. gondii have a higher incidence of delivering male offspring
rather than female offspring, at a rate of 250 males for every 100 females (Kankova, Sulc,
Nouzova, Fajfrlik, Frynta, & Flegr, 2007).
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Rhesus D (RhD) Blood Factor
Gunel, Kalelioglu, Gedikbasi, Ermis and Aydinli (2011), reviewed case studies reviewed,
finding that 75% of the participants had the RhD-positive blood factor, 17.5% RhD-negative
blood factor, and 7.5% discordant tests. These data are supported by previous research reporting
approximately 15% of the world’s population is RhD negative (Branger & Winer, 2006). The
utilization of the anti-D prophylaxis has significantly reduced the incidence of hemolytic disease
in fetuses and newborns (Kumpel, 2008; Pilgrim, Lloyd-Jones, & Rees, 2009).
Latent toxoplasmosis is reported to have 20 to 60% prevalence in the world’s population
(Flegr, Klose, Novotna, Berenreitterova, & Havlicek, 2009). Flegr et al., (2009) provided
evidence of an increased incidence of traffic accidents in toxoplasma-infected military drivers
when compared to toxoplasma free military drivers. In toxoplasma infected military drivers, the
RhD positive blood factor had a protective effect. The 709 toxoplasma infected RhD positive
drivers were found to have significantly fewer traffic accidents when compared to the 181
toxoplasma infected RhD negative drivers (p=0.028). The RhD positive blood factor was found
to have a protective effect on the toxoplasma-induced impaired reaction times (Flegr et al.).
In 2010, Flegr, Novotna, Fialova, Kolbekova, and Gasova reported a significant
difference in toxoplasma-associated personality changes between 302 RhD positive and RhD
negative T. gondii infected blood donors in Prague. The Cattell’s 16PF and Cloninger’s
Temperament and Character Inventory (TCI) personality instruments were utilized to identify
differences when comparing personality of RhD positive and RhD negative T gondii infected
patients. The Cattell’s 16PF is known to have opposite results for males and females with latent
toxoplasmosis, thus analysis was repeated separately for males and females to accommodate for
the known differences. The results from this research support the suggestion of a protective

16

effect of RhD positive blood factor on latent toxoplasmosis personality changes (Flegr et al.,
2009).
Prenatal Depression
Maloni, Park, Anthony and Musil (2005) conducted a study designed to replicate three
previous studies measuring depressive symptoms of 89 hospitalized high-risk antenatal women
between 20-33 weeks gestation on bed rest across time periods (Heaman, 1992; Maloni et. al.,
1993; Mercer & Ferketich, 1988). The pregnant women’s depressive symptoms were measured
utilizing three standardized instruments; Multiple Affect Adjective Checklist-Revised (MAACLR), Profile of Mood States (POMS), and Center for Epidemiologic Studies of Depression Scale
(CES-D). The study purpose was to measure the depressive symptoms to provide evidence of
validity and reliability of the scores utilizing the three instruments. The women within the study
were diagnosed as high-risk antenatal patients due to the increased concern for their medical
outcomes to either themselves or their fetuses. The results of the study provided evidence of
validity and reliability of the scores utilizing the MAACL-R and the POMS to detect change
over time. The measurement instruments were given upon admission, at 2 weeks and at 4 weeks.
Convergent validity was recognized as moderately high for all time frames. Test-retest reliability
correlations between the admission and 2 week measurements (n = 89) for the three
measurements MAACL-R, POMS, and CES-D were .57, .61, and .63, respectively, and from
admission through 2 and 4 weeks (n=37). The MAACL-R and POMS remained significantly
correlated .61, .43, .42, .66, .71, and .50, respectively, across time. This research supports the
development of interventions based on accurate assessment of the depressive symptoms, utilizing
either of the MAACL-R and the POMS standardized instruments (Maloni et al.).
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Lancaster, Gold, Flynn, Yoo, Marcus, and Davis (2010) provide a systematic review of
risk factors for depressive symptoms during pregnancy. Approximately 12.7% of pregnant
women will experience a major episode of depression during pregnancy and within a year of
childbirth. The American College of Obstetrics and Gynecologists recognize the importance of
depression during pregnancy enough to warrant recommending that all pregnant women be
screened for depression during each trimester (American College of Obstetricians and
Gynecologists, 2006). Limitations of the systematic review were recognized; the cross-sectional
designs limited the ability to draw causality conclusions and the screening tools used were not
diagnostic of depression and utilized various cutoffs, therefore the predictability of the risk
factors was limited. Although limitations were recognized the significance of recognizing
depressive symptoms and predictive risk may facilitate more effective interventions for
prenatal/postnatal depression (Lancaster et al.).
To date, only one study of prenatal depression and anxiety in women positive for T.
gondii was found (Groer et al., 2011). Of the 414 pregnant women measured at between 16-25
weeks gestation, the 44 T. gondii positive women had a correlation of higher T. gondii
immunoglobulin titer related to anxiety and depression during pregnancy. The Profile of Mood
States- depression/dejection score (POMS-D) was utilized to measure the depressive symptoms
of the subjects (Groer et al.). Bansil et al.’s(2010) research suggested that depression was
associated with adverse maternal and fetal outcomes. Bansil reported the estimated prevalence of
depression during pregnancy ranged from 7.4% to 15%. Depression has negatively influenced
pregnancy outcomes through the correlation of depression to harmful health behaviors such as
drug abuse, alcohol abuse, self-medication, and cigarette use, poor nutrition with inadequate
weight gain, which leads to inadequate placental function leading to adverse fetal outcomes
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(Bansil et. al.). These significant negative outcomes support the need for screening during
pregnancy for T. gondii (Groer et al.).
Post-natal Depression
The World Health Organization estimates that depression will be the second leading
cause of premature death and morbidity by 2020 and suicide is one of the most common causes
of maternal death in the year following delivery in developed countries (World Health
Organization, 2012). A critical analysis of the literature on post-natal depression (PND) was
conducted by Wylie, Hoolins-Martin, Marland, Martin and Rankin (2011). Girardi et al. (2012)
found higher risk for depression and suicide in the post-partum period. Post-natal depression is
characterized by “depressed mood, hopelessness, anxiety, excessive fatigue, psychomotor
agitation, appetite and sleep disturbance, guilt and/or feelings of inadequacy” (Wylie et al., p.
49.). Beck (2001) identified 13 predictors of post-natal depression which included prenatal
depression. Also the National Institute for Health and Clinical Excellence (NICE) (2007)
incorporated the concept of predicting and detecting mental health problems related to
recognizing mental health problems during pregnancy to include prenatal depression as a
predictor of post-natal depression.
British National Institute for Health and Care Excellence (NICE) clinical guidelines
recommends that early detection of the predictive signs of post-natal depression may afford more
effective evidenced-based interventions for decreasing the incidence of post-natal depression and
the adverse emotional effects on women and children (NICE). NICE guidelines recognize postnatal depression as part of a continuum and has provided recommended questions to facilitate a
more accurate diagnosis of post-natal depression through the utilization this continuum and the
predictive value of prenatal depression (NICE). High quality interventions developed as a result
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of this early recognition and more consistent use of the predictor, prenatal depression, may lead
to greater prevention of the second leading cause of maternal death in the first year post birth
(Wylie et al., 2011).
Research conducted in China and Jordan provide supportive evidence of an increased risk
of postpartum depression when prenatal depressive symptoms were present resulting in an
increased risk for suicide (Wan, Moyer, Harlow, Fan, Jie, & Yang, 2009; Mohammed, MMid,
Gamble, & Creedy, 2011). The supporting evidence provided by the Ling et al. research of the
associated increased risk of seropositive T. gondii women and suicide rates in women suggest
improved focused interventions for this population (2011).
Gaps in Research
Evidence was reviewed of the negative behavioral and personality changes related to the
long-term influence of the parasite, Toxoplasma gondii and the negative T. gondii influence on
prenatal depressive symptoms. Evidence was reviewed discussing the protective effect of RhD
positive blood factor on the latent T. gondii infected subjects. Research conducted in 20
European countries resulted in an association of seropositive T. gondii women and suicide rates
(Ling, Lester, Mortensen, Langenberg, & Postolache, 2011). However there is no research to
date examining the potentially protective effect of RhD positive blood factor on T. gondii
infected pregnant patients with depressive symptoms. Identifying this unique relationship
between latent toxoplasmosis, prenatal depressive symptoms, and the protective effect of RhD
positive blood factor may support the need for routine prenatal screening for toxoplasmosis and
allow for improved interventions in postnatal depression prediction resulting in fewer suicides,
the second leading cause of maternal death during the first year post delivery.
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Chapter Three
Method
The purpose of the research was to explore the possible protective effect of RhD positive
blood factor on prenatal depressive symptoms in T. gondii positive pregnant patients. Identifying
the possible protective effect of RhD positive blood factor may provide information to improve
interventions for the treatment of post natal depression. Chapter three describes the methodology
utilized within the research. The chapter begins with an introductory section followed by the
identification of the design with rationale, a description of the setting, population, and sample
including inclusion and exclusion criteria. Instrumentation is described and validity and
reliability of the scores were reviewed. Procedures are described in detail to include Institutional
Review Board submission and approvals, recruitment, informed consent, and data collection
procedures. The data analysis plan and rationale of analysis are included.
Design
The research is a secondary data analysis of the parent study on the relationship between
T. gondii and prenatal depression (Groer et. al., 2011). The design of this research was a crosssectional design. Exploratory research seeks to investigate the phenomenon and the manner in
which it is manifested and other factors to which it is related. The researcher sought to explore
the possible protective effect of Rhesus D positive blood factor on Toxoplasma-related
depressive symptoms in pregnancy. Figure 1 represents the Logic model for the research.
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Ethnicity

Race
Depressive
Income

symptoms

Age

Stress
MaritalStatus

RhD

T. gondii
Titer
Figure 1 - Logic Model
iter

Setting
The original data were obtained at two large obstetrical practices which were under the
auspices of the University of South Florida Department of Obstetrics and Gynecology in Tampa,
Florida. These practices supervised over 2500 births per year therefore 600 women between 1625 weeks gestation were not difficult to recruit. The setting for the secondary data analyses was
the lab at the University of South Florida, Tampa, Florida. The RhD status of the participants
was already gathered by Groer’s research team at Tampa General Hospital from medical records
and recorded on Excel spreadsheets and subsequently added to the parent research. The
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researcher was granted access to the 217 de-identified participants’ blood samples which were
not yet tested for T. gondii when the initial study was done and these samples were analyzed for
T. gondii in the lab at the College of Nursing on the University of South Florida, Tampa, Florida.
Population and Sample
The target population was healthy pregnant women 16-25 weeks gestation (n=631)
recruited by two large obstetrical practices by trained recruiters from 2006-2009. Participants
were given information about the research and provided informed consent at a prenatal visit and
were enrolled at a subsequent visit. Of those eligible, 44% declined to participate. Exclusion
criteria included immune diseases, immune altering medications, in vitro fertilization, human
immunodeficiency virus disease, illegal drug abuse, extreme thinness, and age <18 and >45
years of age. All participants were evaluated for depressive symptoms.
The University of South Florida is located within an ethnically diverse city. The
population of Tampa, Florida, at the time of the parent research was 317,647. With an ethnicity
breakdown of 64.2% Caucasian, 26.1% Black or African Americans, 0.4% American Indian or
Alaskan Native, 2.2% Asian. 0.1% Native Hawaiian or other Pacific Islander, and 19.3%
Hispanic or Latino (http://quickfacts.census.gov). The sample (n=631) was representative of the
ethnically diverse population.
Measures
All participants completed a demographic questionnaire which solicited information
regarding age, race, income, education, family history of thyroid disease, height, weight,
exercise, problems during labor, birth history, mode of delivery, infant gender, postpartum
complications, yearly income, family size, the presence of any chronic or acute health problems,
smoking, current medications, birth history, work status, exercise, and breastfeeding or bottle-
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feeding history. For the purposes of the secondary data analyses, the author examined ethnicity,
race, income, marital status, age, stress, level of depressive symptoms, RhD blood factor status
and T. gondii titer.
Profile of Mood States
The Profile of Mood States (POMS) (McNair et al, 1992) is a 65-item instrument
designed to elicit feelings over the past week, including the day of measurement. There are six
subscales: tension-anxiety, depression-dejection, anger-hostility, vigor-activity, fatigue-inertia,
and confusion-bewilderment. Experience of mood is reported on a 5-point summated rating
scale, Likert-type, with responses ranging from 0 (not at all) to 4 (extremely). The scores of the
POMS have been found highly reliable and valid in a number of studies of adults in a variety of
life circumstances. The internal consistency ranges from .87 to .92 and test-retest reliably from
.68 to .74 (McNair et al.). The POMS was considered ideal for assessing the whole range of
depressive symptoms in postpartum.
Profile of Mood States (POMS-D)
The POMS-depression/dejection score (POMS-D) demonstrated a high correlation with
the Beck’s Depression Index-II (r = 0.81) (Malouff, Schutte, & Ramerth, 1985). In the parent
research the POMS was selected because it is known as an excellent screening instrument for
dysphoric disorders. The aims of the parent research were to examine general negative moods
during pregnancy and through postpartum period. The depression subscale (POMS-D) includes
15 items that may be used as a stand-alone measure. The response metric: (0) Not at All (1) A
Little (2) Moderately (3) Quite a Bit (4) Extremely, quantifies the frequency of experiencing a
feeling over the duration of a day and over the past 7 days. Higher scores on the POMS indicate
higher levels of dysphoric moods. Reliability of the POMS scores as indicated by alpha
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coefficients of .95 for depression and .92 for anxiety is favorable (Conn, Taylor, & Abele, 1991;
Boyle, 1987).
Perceived Stress Scale

The Perceived Stress Scale (PSS) was utilized to measure the “degree to which situations
in one’s life are appraised as stressful” (Cohen, Karmarck & Mermelstein, 1983, p.385). In the
parent study the 14-item, likert-type scale, was utilized to measure the participants’ level of
perceived stress. The scale ranges from 0 (never), 1 (almost never), 2 (sometimes), 3 (fairly
often), and 4 (very often). Internal consistency was demonstrated at .84, .85, and .86,
respectively, in three samples of young adults. Convergent and criterion validity were found to
be excellent, the predictive validity declined over time (Cohen, Karmarck, & Mermelstein).
RhD Blood Factor
For the purposes of this secondary data analysis, the RhD blood factor in the parent data
base was recoded to either negative or positive, RhD negative (0) and RhD positive (1). The
researcher received permission from the graduate student, who collected the RhD blood factors,
to utilize the RhD blood factors collected from her research.
T. gondii
In the parent research 414 participants’ stored blood samples (-80°C) from 2006-2009
were assessed for quantitative IgG antibodies to whole Toxoplasma organisms. The results were
defined as positive or negative based on comparison with the reactivity of specific antibody
standards assayed with the plasma samples. A positive T. gondii infection was determined at a
level greater than 18 International Units (IU).
For the purposes of the secondary analysis Dr. Groer’s laboratory conducted the assay of
the remaining 217 samples utilizing the VIR-ELISA assay and Dr. Groer reran all of the
previously positive titers (N=44) with the same assay kit so that results were comparable.
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Procedures
Dr. Maureen Groer, the principal investigator of the parent study granted permission for
the researcher to utilize existing data.
Institutional Review Board (IRB) Submission
Institutional Review Board approval was required for the modification of the parent IRB
for the secondary data analyses. Permission for the researcher to be added to the original
approval was submitted by the principal investigator, Dr Maureen W. Groer. The researcher
requested an expedited IRB to be allowed access to the data from the parent research. All of the
data and specimens utilized within the research remained de-identified to the researcher.
Contact/Recruitment
Official participant recruitment was conducted in the parent research. No additional
recruitment was required for these research questions. Inclusion and exclusion criteria for the
secondary analysis remained the same. Exclusion criteria are described earlier in sample section.
Informed Consent
Informed consent was conducted in the parent research per procedure. There was no
additional informed consent required for the secondary data analyses.
Data Analysis
Data analysis was performed to answer each research question. Descriptive
statistics were utilized in the parent research to describe the study variables. Data were
examined for normality and log transformed. As in the parent research, a Pearson
correlation was performed between the T. gondii IgG titers and the POMS-D scores.
Analysis is described through the corresponding aims:
Aim #1: Examine the relationship of ethnicity, race, income, marital status, age, stress,

26

and RhD blood factor on prenatal depressive symptoms in 56 T. gondii infected pregnant
women 16-25 weeks gestation. Aim #1 was addressed utilizing multiple-linear
regression. In Model 1, the POMS-D, was regressed onto the set of demographic
variables; ethnicity, income, marital status, age, and stress. Significance tests on the
regression weights for each predictor were used to determine importance. An R²= .20 was
utilized to define level of fit, df=6.
Aim #2: Examine the relationship of T. gondii titer and prenatal depressive symptoms. T. gondii
titer was added to the Model 1, resulting in df=7.
Aim #3: Examine the relationship of Rh status and prenatal depressive symptoms. The Rh status
was added to Model 1 resulting in remaining df=8.
Aim #4: Examine the moderating effect between Rh status and T. gondii on prenatal
depressive symptoms. A product term was created to identify the test for the moderating
effect. The T gondii titer, Rh status and product term will be added to Model 1 to test
for the moderating effect (interaction) effect of Rh resulting in df=9.
In the parent research data, there was a positive correlation of T. gondii IgG titer with the
POMS-D (r = .37; p < .01) with the relationship remaining significant when controlling for the
effects of race, number of pregnancies, cigarette smoking, and age. Scatter plots from parent
research reflect the POMS depression scores increased as the T. gondii titers increased. The
researcher expected that when adding the additional participants’ T. gondii results the
relationships would remain significant. There has been research data supporting the protective
effect of positive RhD blood factor (Flegr et. al., 2009, 2010), therefore, the researcher expected
to find the effect of positive T. gondii on depressive symptoms to be moderated by the positive
RhD blood factor. Due to the multiple influences of the covariates on prenatal depressive
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symptoms, the RhD positive test of interaction was conducted while controlling for the
covariates, ethnicity, race, income, marital status, age, and stress, known to contribute to
depression.
A fundamental component of research is the critical appraisal of the statistical analysis of
the data, and thus the magnitude of the influence of the independent or predictor variables on the
dependent variable, the effect size (Polit & Sherman, 1990). In the parent research there was a
significantly positive correlation of the T. gondii IgG titer with the POMS-D depression subscale
(r =.37, p <.01), with the relationships remaining significant when controlling for the covariates.
The standardized differences between the means of the groups were divided by the pooled
standard deviations to elicit a Cohen’s d, medium effect size, 0.5. To detect a medium effect size
with .05 criterion of statistical significance level, and resulting power of .80, the sample size of
54 was required. In the parent data 10.5% of the original 414 participants tested positive for T.
gondii, so it was expected that approximately 23 of the additional 217 participants would test
positive for T. gondii.
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Chapter Four
Results
Preliminary analyses
Missing data and normality. Of the 631 participant’s blood samples in the parent
research, 414 participants were tested for T. gondii resulting in 44 participants positive for the
infection. The analysis of the remaining 217 participants’ blood samples resulted in an additional
12 participant’s positive for the T. gondii infection. To achieve a more comparable sample the
previous 44 positive blood samples were rerun by Dr. Groer with the same assay as the 12 new
T. gondii positive blood samples. Three samples of the 44 previously reported as positive had a
result of less than 18 IU/ml, a negative result for T. gondii in the rerun. The combined samples
resulted in a total sample of 56 participants positive for T. gondii infection.
Data were examined utilizing SPSS FREQUENCIES, DISTRIBUTIONS and exploration
of means to identify skewness, outliers and missing values. Data were transformed using
Logarithm (10) to reduce skewness, the number of outliers and improve the normality of the data
(Tabachnick & Fidell. 2007).
Pearson correlation was utilized for the correlation of the interval level data. Both listwise
and pairwise Pearson correlations were conducted. A listwise Pearson correlation was conducted
to identify the number of variables that were identified for both variables, T. gondii (Toxoigmg)
and RhD positive blood factor (RHpn). Utilizing pairwise Pearson correlation the researcher was
able to see how many variables were present independently and thus the researcher was able to
identify the degree of correlation and sample size in order to determine if the utilization of the
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variable resulting in a decrease of sample size was reasonable. Upon examination of the
variables, the addition of the variables, income and marital status, would reduce the already
small sample size to less than 22. Also there was no significant relationship between these
variables and the dependent variable, therefore income and marital status were eliminated from
the models. The Rhesus positive blood factor variable was also found to be missing in 11
participant’s reducing the sample size to 45.
Description of the sample. Participants ranged in age range of 19-44 years of age
(M=29.44; SD=6.61). A majority of the sample self reported race as Hispanic origin (n=25;
55.6%), while 12 participants self-reported as Caucasian (26.7%), six participants self-reported
as African American (13.3%), and two self-reported as Asian/Pacific Islander (3.6%). The
ethnicity of the population was primarily Hispanic (n=25; 55.6%). The racial distribution of the
sample of positive T. gondii participants is described in Table 1.
Table 1.
Racial distribution of sample of positive T. gondii participants
Race

N

%

Hispanic Origin

25

55.6%

Caucasian

12

26.7%

African American

6

13.3%

Asian/Pacific

2

3.6%

Additional demographic information analyzed in the study included income and marital
status. Six participants reported income less than $14,999 (13.3%), three participants reported
income less than $24,999 (6.7%), seven reported income less than $39,999 (15.6%), seven
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reported income greater than 40,000 (13.3%) with twenty-three (51.1%) declining to report level
of income. Marital status was reported as thirteen (28.9%) single, fifteen (33.3%) married, one
(2.2%) divorced, and sixteen (35.6%) declined to answer.
Psychological variables. The mean score of the total POMS-depression/dejection score
(POMS-D) score was 6.93 (N=45; SD=7.42) with range from 00 to 38. Higher scores indicate
more depressive symptoms. The mean score for the Perceived Stress Scale Total score,
(PSSTOT), was 21.8 (N=45; SD=6.79) with a range from 6 to 37. High scores also represent a
higher degree of perceived level of stress (Cohen et al., 1983).
Physiological variables. The overall mean for the 45 participants positive for T. gondii
was 85.08 IU (SD=44.72) with range from 18 to 200. The cut point for determining positive T.
gondii infection was greater than 18 International units (IU).
The RhD blood factor was reported as negative (0) or positive (1). There were forty
participants with the positive RhD blood factor (88.9%) and five participants with a negative
RhD blood factor (11.19%). These percentages are the normal percentage distribution related to
positive and negative RhD blood factors in the overall population.
Pearson correlations with respective means and standard deviations are represented in
Table 2. As previously demonstrated in prior research (Groer et al., 2011), positive T. gondii and
stress were significantly correlated to prenatal depressive symptoms. The secondary analyses
also resulted in a significant correlation between positive T. gondii and stress to prenatal
depressive symptoms; positive T. gondii r=.50, p < .01 and stress r=.34, p < .05. These
correlations support evidence from the parent research. There was no correlation of RhD positive
blood factor with the dependent variable, prenatal depressive symptoms. The interaction of T.
gondii and RhD (TxR) was significantly correlated, when adding the T. gondii to the product
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term, with prenatal depressive symptoms. The correlations between the variables utilizing
pairwise deletion; POMS-D total score (Tpomsd), age, Hispanic ethnicity (Hisp), Perceived
Stress Scale total score (PSSTOT), Toxoplasma gondii (Toxoigmg), RhD positive blood factor
(RHpn) and the interaction product term of T. gondii and RhD Positive blood factor (TxR) are
represented in Table 2.
Table 2.
Correlations prenatal depressive symptoms, psychosocial and physiological variables

Total POMS-D

Total POMS-D

Age

1.000

-.100

.221

.340*

1.000

.212

-.094

1.000

Age
Hisp

Hisp

PSSTOT

PSSTOT

T. gondii

RHpn

TxR

.497**

.143

.344*

-.112

-.257

-.118

.009

.200

.063

.314

1.000

.234

-.063

.203

1.000

-.060

.336*

1.000

.315*

T. gondii
RHpn
TxR

1.000

Mean

.700

29.44

.489

21.80

85.09

.889

-.839

SD

.454

6.61

.506

6.79

44.72

.318

9.29

N

45

45

45

45

45

45

45

p = .05 * p = .01** T. gondii X Rhpn = (TxR)

Analyses of the Study Aims
Sequential regression was utilized to determine if the addition of the variables, T. gondii
and the RhD positive blood factor, and the product variable, while controlling for the
demographic variables would suggest these variables were contributing factors towards lower
prenatal depressive symptoms. Analysis was performed using the SPSS REGRESSION. Table 2
as described earlier displays the correlations between the variables utilizing pairwise deletion.
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Aim #1: Examine the relationship of ethnicity, race, income, marital status, age,
stress, and RhD blood factor on prenatal depressive symptoms in 45 positive T. gondii
infected pregnant women 16-25 weeks gestation. Aim #1 was analyzed utilizing multiple
linear regression. In Model 1, the POMS-D, depressive symptoms, were regressed onto
the set of demographic variables; ethnicity, race, income, marital status, age, and stress.
Significance tests on the regression weights for each predictor were used to determine
importance. An R²= .20 was utilized to define level of fit, degrees of freedom (df) =6.
The variable race was found to not be a dichotomous variable therefore was removed
from the regression. As previously described in this chapter the pairwise correlation
demonstrated the rationale for reducing the number of variables utilized in the regression
model to ethnicity (Hisp), age, and stress, reducing the df=3 for Model 1. Model 1
equation, F (3, 41) = 2.941, p < .05, R=.421 and R²=.18. The adjusted R² value of .12
indicates that more than 12% of the variability in prenatal depressive symptoms is
predicted by ones’ age, being Hispanic, and level of stress.
Aim #2: Examine the relationship of T. gondii status and prenatal depressive symptoms.
T. gondii titer was added to the Model 1, resulting in df=4.Table 3 illustrates the change from
Model 1 to Model 2 with the addition of the positive T. gondii variable to the Model 2. In this
equation, F (4, 40) = 4.737, p < .01, R=.567. The addition of T. gondii added to the prediction of
prenatal depressive symptoms, R²=.32. The F test for the change in R² when comparing Model 1
to Model 2 was significant at 8.50**.
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Table 3
Change from Model 1 to Model 2
Prenatal Depressive Symptoms
Model 2
Variable

Model 1 B

B

95% CI

Constant

.363

-.070

-.656 - .797

Age

-.008

-.004

-023 - .014

Hispanic

.219

.136

-.112 - .385

PSSTOT

.022

.016

.002 - .034

.004

.001 - .007

T. gondii
R2

.177

.321

F

2.941*

4.737**

ΔR2

.144

ΔF

8.508**

Note. Dependent variable = POMS-D total score
N = 45. CI = Confidence interval.
*p < .05. **p < .01.

Aim #3: Examine the relationship of Rh status and prenatal depressive symptoms. The
RhD positive blood factor status was added to Model 1 resulting in remaining
df=5. The representation of the regression equation comparing Model 2 with Model 3
with the addition of the RH positive blood factor (RHpn) is represented in Table 4. The
comparison displays F (5, 39) = 4.169, p < .01, R=.590 and R²=.348. The adjusted R² of
.27 indicates that the addition of the RhD positive blood factor, when added into the
model, minimally increased the variability predicted by the previous model. The F test
for the change in R² when comparing Model 2 to Model 3 was not significant at .212. The
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comparison of the models is displayed in Table 4.
Table 4
Change from Model 2 to Model 3
Prenatal Depressive Symptoms
Model 3
Variable

Model 2 B

B

95% CI

Constant

-.070

-.279

-1.190 - .632

Age

-.004

-.001

-.020 - .019

Hispanic

.136

.113

-.137 - .363

PSSTOT

.016

.017

.001 - .035

T. gondii

.004

.004

.001 - .007

.247

-.147 - .640

RHpn
R2

.321

F

4.737**

.348
4.169**

ΔR2

.027

ΔF

1.61

Note. Dependent variable = POMS-D
*p < .05. **p < .01.

Aim #4: Examine the moderating effect between Rh status and T. gondii on prenatal
depressive symptoms.
A product term was created to identify the test for the moderating effect of T
gondii status and Rh status (TxRh). The interaction was added to Model 1 to test for the
moderating effect (interaction) effect of Rh resulting in df=6. The regression of the moderating
factor onto the dependent variable is represented in Table 5 with the comparison of Model 3 to
Model 4. When adding all of the independent variables including the interaction TxRh, F (6, 38)
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= 3.455, p < .01, R=.594 and R²=.353. The interaction was not statistically significant (p = .605)
representing no moderating factor. The F test for the change in R², when comparing Model 3 to
Model 4, was not significant at .272. The comparison of the models is displayed in Table 5.
Table 5.
Change from Model 3 to Model 4
Prenatal Depressive Symptoms
Model 4
Variable

Model 3 B

B

95% CI

Constant

-.279

-.205

-1.169 - .759

Age

-.001

-.001

-020 - .019

Hisp

.095

.095

-.167 - .357

PSSTOT

.016

.016

.003 - .034

T. gondii

.004

.004

.001 - .007

RHpn

.210

.210

.212- .632

TxRh

.004

R2

.348

F

4.169**

-.011 - .019
.353
3.455**

ΔR2

.005

ΔF

.272

Note. Dependent variable = POMS-D *p < .05. **p < .01.

The independent variables of stress and T. gondii were consistently found to
be significant predictors of prenatal depression, where the addition of the RhD
positive blood factor did not significantly contribute when regressed onto prenatal
depressive symptoms. Model 1, with the log of age, ethnicity and stress in the
equation, had a R²=.177, (adjusted R²= .12), F inc (3, 41) = 2.941, p < .05. In Model 2,
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after the square root of T.gondii was added to the prediction of prenatal depressive
symptoms by the age, ethnicity and stress, resulted in R²=.321, (adjusted R²=.25), F inc (4,
40) = .006, p < .01. The addition of square root of T.gondii to the equation with age,
ethnicity, and stress resulted in a significant increment of R². In Model 3, with RhD
positive blood factor added to the prediction of prenatal depressive symptoms by T.
gondii and square root of age, ethnicity and stress, the result was R²=.348, (adjusted R² =
.27), F inc (5, 39) = .212. The addition of the RhD positive blood factor did not reliably
improve R². In Model 4, the addition of the product variable TxRh to the prediction of
prenatal depressive symptoms by T. gondii and square root of age, ethnicity, stress, T.
gondii, and RhD positive blood factor, the result was R²=.353, (adjusted R² = .25), F inc
(1, 37) = .605. The addition of the product variable did not reliably improve R². The
addition of neither the positive RhD blood factor nor the product variable significantly
improve the reliability of R² in predicting prenatal depressive symptoms.
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Chapter Five
DISCUSSION
The purpose of this study was to examine the possible protective effect of RhD
positive blood factor on prenatal depressive symptoms in pregnant women with T. gondii
infection. The cross-sectional design was utilized to answer the question “Does positive RhD
blood factor provide a protective effect on prenatal depressive symptoms of patients infected
with T. gondii when controlling for ethnicity, race, income, marital status, age and stress?” The
conceptual model hypothesized that there was a relationship between socio-demographic
variables (age, income, marital status, race, and ethnicity) and prenatal depressive symptoms.
After preliminary analyses utilizing Pearson correlation, the variables income and marital status
were eliminated from the analyses due to the significant reduction in sample size if utilized. Due
to previous research evidence, a relationship between T. gondii and stress on prenatal depressive
symptoms was also proposed. Although prior research (Flegr et al, 2005; Flegr et al, 2008; Flegr
et al, 2009, & Flegr et al, 2010) provided evidence of the protective effect of RhD positive blood
factor on the variable outcomes in T. gondii infected individuals, there was no research to date
exploring a protective effect on pregnant women infected with T. gondii. Therefore, this study
proposed a possible protective effect of positive RhD blood factor inT. gondii infected pregnant
women on prenatal depressive symptoms. Finally, a moderating effect of RhD positive blood
factor on the relationship between T. gondii and prenatal depressive symptoms was proposed.
Pearson correlations and multiple regression were utilized to explore the aims of this study.
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Sample size may account for our lack of findings of 45 pregnant T. gondii positive
women. The percentage of women with RhD positive blood factor versus negative was 88.9%
and 11.2%, respectively. These percentages are comparable to the research evidence provided by
Branger and Wise (2006). The power analysis of the secondary analyses suggested 54
participants would result in a medium effect. Missing RhD blood factor data resulted in a
reduction of the original sample of 56 pregnant participants infected with T. gondii to an N=45.
The reduction of sample size may have attributed to the nonsignificant findings. The parent study
did, however, find a significant relationship between stress and positive T.gondii seropositivity
on prenatal depressive symptoms, which was replicated in this research.
Toxoplasma gondii infects approximately 30% of the population worldwide, with a
higher prevalence in women than men, (23.7% versus 10.9%), (Flegr & Striz, 2011). The CDC
estimates that 22.5% of the population 12 years and older in the United States is infected with T.
gondii (CDC, 2013). Although Kolbekova, Kourabatova, Kodym, and Flegr (2007) reported an
overall seroprevalence of 29-37% in pregnant women world-wide, the percentage of pregnant
participants with positive T. gondii infection in the parent research was 9% of the 631 sample.
The CDC (2013) named toxoplasmosis as one of the five leading neglected parasites in the
United States, calling it the leading cause of death which is attributed to food borne illness.
Acute toxoplasmosis continues to be responsible for devastating effects for the newborn infant
including hydrocephaly, intra-cerebral calcifications, microcephaly, and miscarriage in the
immune compromised (Montoya & Remington, 2008). To date, although literature regarding
toxoplasmosis is distributed to pregnant women and they are encouraged them to avoid cat litter,
wash produce well before consumption, and eat well cooked meat products, there is no
recommendation for routine screening for T. gondii in all pregnant women.
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There was a significant relationship between the level of stress and T. gondii infection on
prenatal depressive symptoms. Higher levels of stress were associated with higher prenatal
depressive symptoms reported by the T.gondii infected pregnant women. Both T.gondii infection
and stress were associated with depressive symptoms. Which of the variables contributed more is
unable to be ascertained. Although no significant relationship was demonstrated between T.
gondii and stress, one might speculate that the increased stress may have reduced the body’s
ability to fight the T. gondii infection. Although there is evidence supporting the increase in
depressive symptoms with T.gondii infection, this research did not examine the length of time
the participants had the T. gondii infection. Research evidence suggests that as the length of the
T. gondii infection or latency increases, so do the psychiatric disorders and personality changes
which could deteriorate immune response to disease (Flegr & Hrda, 1994; Flegr & Havilcek,
1999; Flegr, Kodym, & Tolarova, 2000; Havlicek et al., 2001; Flegr, 2007; & Flegr, 2010). In
addition, possible reactivation of the dormant T. gondii tachyzoites may have contributed to the
inability of the body to fight the infection (Stokkeman et al., 1996). The ability to determine the
latency and or reactivation state of the T. gondii infection would strengthen the results of this
research.
Also, 51% of the sample self-reported Hispanic ethnicity. Research is suggestive of a
higher T. gondii seroprevalence in women of Hispanic ethnicity which was supported by a
significant relationship between T. gondii infection and Hispanic ethnicity in this research
(Jones, Kruszon-Moran & Wilson, 2003; Groer et al, 2011). However, there was not a significant
relationship between Hispanic ethnicity and prenatal depressive symptoms.
Although Flegr et al. (2009) found a significant protective effect of the positive RhD
blood factor in T. gondii infected patients; this study did not find evidence of a significant
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protective effect. When examining the relationship of the RhD positive blood factor and
depressive symptoms, the small sample size cannot be ignored. Thus, the conceptual model of
this research was not supported by the evidence. Although previous research evidence (Flegr et.
al, 2005; Flegr et. al, 2008; Flegr et. al, 2009; Flegr et. al., 2010) supported the protective effect
of RhD positive blood factor on T. gondii infected patients, no studies had been conducted on
pregnant women infected with T. gondii. Because of the significant relationship between T.
gondii infection and prenatal depressive symptoms and the subsequent predictive nature of
prenatal depressive on post partum depression (NICE, 2007; Beck, 2001; Stillwaggon et al.,
2011; Whisman et al., 2011; Girardi et al., 2012) further research on this relationship is
warranted. This suggested research could be accomplished if pregnant women were screened for
the presence of T. gondii infection routinely upon diagnosis of pregnancy. Improved screening
for T. gondii may lead to improved surveillance of post partum depression and suicide post
delivery to avoid or reduce the negative maternal and fetal outcomes.
Limitations
The sample size in this study is a limitation. Although the power analysis to elicit a
medium effect suggested a sample size of at least 54 participants, due to missing data on the 57
positive participants infected with T. gondii, the sample size was reduced to a total of N=46. The
small sample increases the risk of Type II error. A larger sample size of pregnant women,
positive for the T. gondii infection, would allow for further exploration of the possible protective
effect of positive RhD blood factor related to prenatal depressive symptoms. To date there has
been only one study to identify the relationship between T. gondii infection in pregnant women
and depressive symptoms. Therefore, further research is needed to examine this suggested
relationship.
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The cross-sectional, single group, design represents a collection of data from participants
at a specific point in time. A cross-sectional design, although easy to do and economical, has no
ability to identify which of the variables had the most influence overtime in this study. Also, the
cross-sectional design limits the ability to draw causality conclusions. With the strong evidence
of hosts’ response to the T. gondii infection over time, a longitudinal study may provide a more
in depth look at the data over time. This type of study may allow for a more in depth examination
of the effects of individual variables over time.
Self-reporting was a limitation of the data collection of the psychological variables. Selfreported data, although versatile and directly to the point, is a weakness (Polit & Beck, 2004).
How does the researcher know if the participant really feels the way they say they do or if they
are merely reporting what they believe the researcher wants to hear? Most participants want to be
seen as normal or less ill. The researcher must assume the self reported feelings are real.
Finally, there was some limitation to the T. gondii titers obtained in this study. Although
the researcher attempted to stabilize the results of the titers by rerunning the titers performed on
the parent study with the same manufacturers’ analysis kit as this study, there is still literature
(CDC, 2009) suggesting that the sensitivity and specificity of the ELISA kits vary among
manufacturers. Presently there is no gold standard for which assay kit is preferred.
Implications
Strong evidence has been presented regarding the ability of the T. gondii infection to lay
dormant for years after an acute episode within its human host resulting in specific behavioral
and physiological effects (Flegr et al., 2000; Flegr et al., 2005; Flegr & Striz, 2011). Latent
Toxoplasma-induced personality changes have been reported with possible links to psychiatric
disorders (Lindova, Priplatova, & Flegr, (2011). The World Health Organization (2012) reported
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that suicide is one of the most common causes of maternal death in the first year after delivery.
Having provided evidence of the relationship between positive T. gondii and increased
depressive symptoms, the ability to study T. gondii as it relates to prenatal and post partum
depression more thoroughly has the potential to reduce this significant negative outcome. The
prior research evidence suggests being of Hispanic ethnicity has a strong correlation to positive
T. gondii infection. This patient population would need to be included in any future research.
Finally, although this study did not provide significant evidence of the protective effect of
positive RhD blood factor on T. gondii-related depressive symptoms, there is strong evidence of
a protective effect of RhD positive blood factor on the psychiatric symptoms of the T. gondii
infection (Flegr et al., 2008; Flegr et al., 2009; Flegr et al., 2010). Further research is warranted
to include pregnant women positive with the T. gondii infection and their related depressive
symptoms. This research must include screening for the T. gondii infection among pregnant
women. This screening may be the catalyst to the ability to predict prenatal and post partum
depression among this vulnerable population.
Conclusion
The evidence of the relationship between T. gondii infected pregnant women and
depressive symptoms was significant. Although not the focus of this research, there is also strong
research evidence of devastating outcomes related to prenatal and post partum depression. The
ability to screen pregnant women for T. gondii is available and should be considered as the next
additional routine testing to be performed on all pregnant women. The identification of T. gondii,
whether acute or dormant, may lead to a decline in the second leading cause of death in pregnant
women in their first year post delivery. Educating pregnant women about the risks of
Toxoplasmosis, when they become pregnant is not enough. The ability to identify a unique
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relationship between latent T. gondii infection, prenatal depressive symptoms, and RhD positive
blood factor may lead to the support needed to provide routine screening. The ability to improve
interventions in predicting post partum depression may result in reducing the second leading
cause of maternal death in the first year after delivery.
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